Effect and Safety of Acupuncture for Type 2 Diabetes Mellitus:A Systematic Review and Meta-analysis of 21 Randomised Controlled Trials

被引:0
|
作者
LI Shu-qing [1 ]
CHEN Jian-rong [2 ]
LIU Mei-lu [3 ]
WANG Yan-ping [1 ]
ZHOU Xu [1 ]
SUN Xin [1 ,4 ]
机构
[1] Evidence-Based Medicine Research Centre, Jiangxi University of Traditional Chinese Medicine
[2] Department of Endocrinology, the First Affiliated Hospital of Nanchang University
[3] Department of Integrated Chinese and Western Medicine,West China Hospital, Sichuan University
[4] Chinese Evidence-Based Medicine Centre, West China Hospital, Sichuan University
关键词
D O I
暂无
中图分类号
R246.1 [内科];
学科分类号
摘要
Objective: To evaluate the effects of acupuncture on hypoglycaemic outcomes in type 2 diabetes mellitus(T2 DM). Methods: Pub Med, Embase, Cochrane Library, and Clinical Trials.gov were searched from inception up to July 2020, to identify randomised controlled trials(RCTs) that enrolled patients with T2 DM and compared acupuncture combined with antidiabetic drugs to antidiabetic drugs alone. The primary outcomes were haemoglobin A1 c(Hb A1 c) and fasting blood glucose(FBG). The secondary outcomes included 2-h blood glucose(2 h BG), fasting insulin(FINS), homeostatic model assessment for insulin resistance(HOMA-IR), and acupuncture-related adverse events. Mean difference(MD) and 95% confidence interval(CI) were used as the effect measure in the meta-analysis. The quality of evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation tool. Results: Twenty-one RCTs(n=1,188) were included. The meta-analytic results showed that the acupuncture group had greater reductions in FBG(MD –6.46 mg/d L, 95% CI –11.95 to –0.98; moderate-quality evidence) and HOMA-IR(MD –1.23, 95% CI –2.16 to –0.31; low-quality evidence), but comparable changes in Hb A1 c(MD –0.39%, 95% CI –0.84 to 1.61; very-low-quality evidence), 2 h BG(MD –4.99 mg/d L, 95% CI –20.74 to 10.76; low-quality evidence), and FINS(MD –1.32 μIU/m L, 95% CI –3.76 to 1.12; low-quality evidence). No data on the incidence of diabetic complications were found. All acupuncture-related adverse events reported were mild. Conclusions: The current evidence suggests that acupuncture, as a complementary therapy to antidiabetic drugs, has a small but statistically significant effect on decreasing FBG and improving insulin resistance. The effects of acupuncture on Hb A1 c, 2 h BG, and FINS remain uncertain. Acupuncture is generally safe in patients with mild diabetes. More evidence for the long-term effects of acupuncture on T2 DM is needed.(Registration No. CRD42018115639)
引用
收藏
页码:463 / 471
页数:9
相关论文
共 50 条
  • [21] Safety of acupuncture in oncology: A systematic review and meta-analysis of randomized controlled trials
    Hoxtermann, Melanie D.
    Haller, Heidemarie
    Aboudamaah, Shaimaa
    Bachemir, Armin
    Dobos, Gustav
    Cramer, Holger
    Voiss, Petra
    CANCER, 2022, 128 (11) : 2159 - 2173
  • [22] Effectiveness of acupuncture on anxiety disorder: a systematic review and meta-analysis of randomised controlled trials
    Xiang-yun Yang
    Ning-bo Yang
    Fang-fang Huang
    Shuai Ren
    Zhan-jiang Li
    Annals of General Psychiatry, 20
  • [23] Effectiveness of acupuncture on anxiety disorder: a systematic review and meta-analysis of randomised controlled trials
    Yang, Xiang-yun
    Yang, Ning-bo
    Huang, Fang-fang
    Ren, Shuai
    Li, Zhan-jiang
    ANNALS OF GENERAL PSYCHIATRY, 2021, 20 (01)
  • [24] Outcomes of Telehealth in the Management of Type 2 Diabetes-A Systematic Review and Meta-analysis of Randomised Controlled Trials
    Nangrani, Nisha
    Malabu, Usman
    Vangaveti, Venkat
    DIABETES, 2018, 67
  • [25] Safety of Linagliptin in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Clinical Trials
    Aljohani, Hadir
    Alrubaish, Fares S.
    Alghamdi, Waad M.
    Al-Harbi, Fawaz
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2024, 58 (04) : 622 - 633
  • [26] Efficacy and safety of intermittent fasting for type 2 diabetes mellitus: A systematic review and meta-analysis of randomized trials
    Chadwick, Joshua
    Ayyasamy, Lavanya
    Kalyanasundaram, Madhanraj
    Parasuraman, Ganeshkumar
    Bagepally, Bhavani Shankara
    Kathiresan, Jeyashree
    Shanmugam, Lokesh
    DIABETES EPIDEMIOLOGY AND MANAGEMENT, 2025, 17
  • [27] Efficacy of flavonoids on biomarkers of type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials
    Liu, Fanling
    Sirisena, Sameera
    Ng, Ken
    CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, 2023, 63 (21) : 4916 - 4941
  • [28] Efficacy and safety of sotagliflozin in patients with type 2 diabetes: meta-analysis of randomised controlled trials
    Kakotrichi, P.
    Avgerinos, I.
    Karagiannis, T.
    Michailidis, T.
    Liakos, A.
    Tsapas, A.
    Bekiari, E.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 256 - 257
  • [29] Effectiveness and safety of selenium supplementation for type 2 diabetes mellitus in adults: a systematic review of randomised controlled trials
    Strozyk, A.
    Osica, Z.
    Przybylak, J. D.
    Kolodziej, M.
    Zalewski, B. M.
    Mrozikiewicz-Rakowska, B.
    Szajewska, H.
    JOURNAL OF HUMAN NUTRITION AND DIETETICS, 2019, 32 (05) : 635 - 645
  • [30] Efficacy and safety of empagliflozin for type 2 diabetes mellitus Meta-analysis of randomized controlled trials
    Zhang, Yun-Jing
    Han, Shi-Liang
    Sun, Xi-Feng
    Wang, Shu-Xiang
    Wang, Hong-Yun
    Liu, Xiao
    Chen, Li
    Xia, Ling
    MEDICINE, 2018, 97 (43)